Camelot Portfolios’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-222
Closed -$6.2K 444
2024
Q2
$6.2K Buy
+222
New +$6.11K ﹤0.01% 452
2018
Q2
Sell
-7,832
Closed -$263K 219
2018
Q1
$263K Buy
7,832
+61
+0.8% +$2.1K 0.12% 157
2017
Q4
$267K Sell
7,771
-31
-0.4% -$1.06K 0.13% 137
2017
Q3
$264K Sell
7,802
-69
-0.9% -$2.22K 0.13% 139
2017
Q2
$251K Sell
7,871
-9,062
-54% -$286K 0.12% 145
2017
Q1
$550K Sell
16,933
-840
-5% -$26.5K 0.27% 98
2016
Q4
$548K Sell
17,773
-2,343
-12% -$71.5K 0.29% 93
2016
Q3
$646K Buy
+20,116
New +$673K 0.35% 85
2015
Q3
Sell
-8,984
Closed -$286K 168
2015
Q2
$286K Sell
8,984
-806
-8% -$26.3K 0.16% 128
2015
Q1
$323K Sell
9,790
-26,946
-73% -$857K 0.19% 125
2014
Q4
$1.09M Sell
36,736
-134
-0.4% -$3.84K 0.62% 47
2014
Q3
$1.03M Buy
36,870
+2,206
+6% +$61.9K 0.6% 44
2014
Q2
$976K Buy
34,664
+7,844
+29% +$224K 0.63% 49
2014
Q1
$817K Sell
26,820
-11,204
-29% -$334K 0.55% 54
2013
Q4
$1.1M Sell
38,024
-4,708
-11% -$137K 0.71% 33
2013
Q3
$1.17M Buy
42,732
+1,158
+3% +$31.5K 0.85% 30
2013
Q2
$1.1M Buy
+41,574
New +$1.15M 0.84% 34

Other funds holding PFE